These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 414402

  • 1. Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer.
    Byar D, Blackard C.
    Urology; 1977 Dec; 10(6):556-61. PubMed ID: 414402
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tryptophan metabolites, pyridoxine (vitamin B6) and their influence on the recurrence rate of superficial bladder cancer. Results of a prospective, randomised phase III study performed by the EORTC GU Group. EORTC Genito-Urinary Tract Cancer Cooperative Group.
    Newling DW, Robinson MR, Smith PH, Byar D, Lockwood R, Stevens I, De Pauw M, Sylvester R.
    Eur Urol; 1995 Dec; 27(2):110-6. PubMed ID: 7744151
    [Abstract] [Full Text] [Related]

  • 6. [Use of thiotepa, in local instillation, as a prophylactic treatment for recurrence of superficial tumors of the bladder].
    Toulouse J, Bouffier B, Etievent JP, Bittard M.
    J Urol (Paris); 1983 Dec; 89(2):85-9. PubMed ID: 6408192
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Preventive value of intravesical thiotepa on the recurrence of Ta-T1 vesical tumors treated by conservative surgery. Apropos of 247 cases a mean follow-up of 88 months].
    Gilloz A, Sauvage I, Gremillet E, Héritier P, Richard A, el Hajj E, Diez-Yanguas J.
    J Urol (Paris); 1987 Dec; 93(4):197-202. PubMed ID: 3119728
    [Abstract] [Full Text] [Related]

  • 10. [Intravesical BCG, mitomycin-C and thiotepa in the prevention of bladder tumor recurrence after operation].
    Wang SH.
    Zhonghua Wai Ke Za Zhi; 1992 Jul; 30(7):410-2, 443-4. PubMed ID: 1301342
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [The recurrence after conservative therapy of bladder cancer. II: The intravesical instillation of anti-cancer drug for preventing recurrence (author's transl)].
    Saito K, Fukushima S, Takahashi Y, Takai S.
    Nihon Hinyokika Gakkai Zasshi; 1980 May; 71(5):449-57. PubMed ID: 6774151
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The biology and treatment of superficial bladder cancer.
    Torti FM, Lum BL.
    J Clin Oncol; 1984 May; 2(5):505-31. PubMed ID: 6427417
    [Abstract] [Full Text] [Related]

  • 18. Intravesical thiotepa in prevention of recurrence of bladder tumour.
    Ghosal SK, Sen DK.
    J Indian Med Assoc; 1980 Nov 01; 75(9):173-4. PubMed ID: 6785360
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.